Preview

PULMONOLOGIYA

Advanced search

https://doi.org/10.18093/0869-0189-2013-0-3-36-40

About the Authors

M. A. Makarova
ФГБУ "НИИ пульмонологии" ФМБА России
Russian Federation


S. N. Avdeev
ФГБУ "НИИ пульмонологии" ФМБА России
Russian Federation


A. G. Chuchalin
ФГБУ "НИИ пульмонологии" ФМБА России
Russian Federation


References

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI / WHO workshop report. Last updated 2010. www.goldcopd.org

2. Andreassen H., Vestbo J. Chronic obstructive pulmonary disease as a systemic disease: an epidemiological perspective. Eur. Respir. J. 2003; 22: 2–4.

3. Celli B.R., MacNee W. ATS / ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS / ERS position paper. Eur. Respir. J. 2004; 23: 932–946.

4. August A.G.N., Noguera A., Sauleda J. et al. Systemic effects of chronic obstructive pulmonary disease. Eur. Respir. J. 2003; 21: 347–360.

5. Rutten F.H., Moons K.G., Cramer M.J. et al. Recognizing heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross-sectional diagnostic study. Br. Med. J. 2005; 331: 1379–1384.

6. Zielinski J., MacNee W., Wedzicha J. et al. Causes of death in patients with COPD and chronic respiratory failure. Monaldi Arch. Chest Dis. 1997; 52: 43–47.

7. Le Cras T., McMurtry I.F. Nitric oxide production in hypoxia. Am. J. Physiol. 2001; 280: 575–582.

8. Малышев И.Ю., Монастырская Е.А., Смирин Б.В. и др. Гипоксия и оксид азота. Вестн. РАМН 2000; 9: 44–48.

9. Кароли Н.А. Некоторые механизмы развития легочной гипертонии у больных хроническими обструктивными заболеваниями легких. Тер. арх. 2005; 3: 87–93.

10. Бородина М.А., Мерзликин Л.А., Щетинин В.В. О механизмах развития легочной гипертонии при ХОБЛ. Пульмонология 2003; 3: 120–124.

11. Бродская Т.А., Гельцер Б.И., Невзорова В.А. Артериальная ригидность и болезни органов дыхания (патофизиологические механизмы и клиническое значение). Владивосток: Дальнаука; 2008.

12. Bartels M.N., Gonzalez J.M., Kim W., De Meersman R.E. Oxygen supplementation and cardiac-autonomic modulation in COPD. Chest 2000; 118: 691–696.

13. Matsui H., Ihara Y., Fujio Y. et al. Induction of interleukin (IL)-6 by hypoxia is mediated by nuclear factor (NF)-κB and NF-IL6 in cardiac myocytes. Cardiovasc. Res. 1999; 42: 104–112.

14. Mulloy E, McNicholas W.T. Ventilation and gas exchange during sleep and exercise in severe COPD. Chest 1996; 109: 387–394.


Review

For citations:


Makarova M.A., Avdeev S.N., Chuchalin A.G. . PULMONOLOGIYA. 2013;(3):36-40. (In Russ.) https://doi.org/10.18093/0869-0189-2013-0-3-36-40

Views: 41378


ISSN 0869-0189 (Print)
ISSN 2541-9617 (Online)